FindTrial
Sign In

Construction of a 3D Bioprinted In Vitro Glioma Model and Its Application in Personalized Adjuvant Treatment Guidance

Construction of a 3D Bioprinted In Vitro Glioma Model and Its Application in Personalized Adjuvant Treatment Guidance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116341
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-31
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Case series:None

Sponsors

West China hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age greater than or equal to 18 years; 2. Preoperative diagnosis of glioma or imaging suggesting glioma recurrence; 3. Ability to independently sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with concurrent malignant tumors; 3. Individuals with communication disorders, poor compliance, or contraindications to the relevant surgical procedures; 4. Other conditions deemed unsuitable for participation in the study by the investigators.

Design outcomes

Primary

MeasureTime frame
Therapeutic response;Receiver Operating Characteristic curve;AUC;—

Secondary

MeasureTime frame
Progression-Free Survival (PFS);Overall survival (OS);Drug Dosage and Treatment Adverse Events;—

Countries

China

Contacts

Public ContactYanhui Liu

Department of Neurosurgery, Westchina hospital of Sichuan University

liuyh@scu.edu.cn+86 189 8060 1509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026